Naomi M. Hamburg, MD, MS
Joseph A. Vita, MD Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Cardiovascular Medicine

MD, Harvard Medical School
AB, Harvard University

Pronouns: she/her/hers



Dr. Hamburg is the inaugural Joseph A. Vita Professor of Medicine, Chief of the Vascular Biology Section, interim Director of the Whitaker Cardiovascular Institute at Boston University School of Medicine and an Attending in the Cardiovascular Medicine Section at Boston Medical Center. Dr. Hamburg is a recognized expert in the field of Vascular Medicine and the clinical translation of Vascular Biology. Her research work seeks to understand approaches to restore vascular health in patients with cardiometabolic disorders, peripheral artery disease, and to evaluate the impact of novel tobacco products and long COVID. Her work has been continuously funded by the National Institutes of Health and foundations since 2006. Dr. Hamburg has held multiple leadership positions in the field of Vascular Medicine including as the Chair of the Peripheral Vascular Disease Council of the American Heart Association, and as a member of the Board of the Society of Vascular Medicine, the American Society of Echocardiography and the Vascular Testing Division of the Intersocietal Accreditation Commission. She co-Chaired the Advanced Training Statement for Vascular Medicine from the American College of Cardiology and the Society of Vascular Medicine. Dr. Hamburg has authored more than 150 scientific papers in the peer reviewed literature and has served on guideline writing committees. She is a past Associate Editor of the journal Vascular Medicine, and current Associate Editor for Circulation Research. She is passionate about improving the care of vascular diseases and reducing the burden of PAD through education. When not working, she enjoys spending time in the mountains hiking and skiing with her husband and two teenage sons.

Diversity, Equity, Inclusion and Accessibility

My father and his parents immigrated to this country after being deported from Eastern Europe during WWII. My grandfather had been an ophthalmologist in a prominent Jewish hospital before the war. After losing much of his family, he had to start anew retaking medical examinations in a foreign language. My family’s journey and history in medicine informs me as a doctor, scientist, and mentor. When I chose to become a cardiologist, I was motivated by the dearth of women in this specialty and the lack of science about women and heart disease. As a scientist, my focus has been on understanding blood vessel health in people with or at risk for cardiovascular diseases. As a clinician and researcher, I have been acutely aware of the disparities in the burden of vascular diseases and actively involved in thinking about solutions to promote health equity. I have participated in creating a national action plan to reduce disparities in peripheral artery disease. In my clinical research studies, we strive to include diverse study participants and think about how to build inclusive research programs. We have studied how drivers of cardiovascular injury that are more prevalent in underrepresented groups including diabetes, tobacco use, and COVID-19 infection impact endothelial function. My mentoring philosophy is to nurture the talents and growth of each person to help them succeed on their personal academic journey. A partnership with Tougaloo College and the AHA SURE and BU STARS programs enhances the inclusion of undergraduates from groups underrepresented in medicine to ongoing research projects. I have also mentored many physicians and scientists making the transition from other countries to training in the US. Together with my entire research team, we strive to develop an inclusive and supportive environment dedicated to promoting scientific curiosity and professional development. Our personal stories and our patients’ stories are the foundation of building a healthier future through discovery.

Section Chief
Boston University Chobanian & Avedisian School of Medicine
Medicine
Vascular Biology

Investigator
Framingham Heart Study


Interim Director
Boston University
Whitaker Cardiovascular Institute


Member
Boston University
Evans Center for Interdisciplinary Biomedical Research




Endothelial Cell Health Across the Spectrum of Cardiometabolic Disease
09/12/2023 - 05/31/2028 (PI)
NIH/National Heart, Lung, and Blood Institute
1R01HL168889-01

Long-Term Endothelial Effects of COVID-19
03/15/2022 - 02/28/2026 (Multi-PI)
PI: Naomi M. Hamburg, MD, MS
Beth Israel Deaconess Medical Center, Inc. NIH NHLBI
5R01HL160003-02

Cardiovascular injury due to tobacco product use
09/01/2018 - 08/31/2024 (Subcontract PI)
American Heart Association NIH NHLBI
5U54HL120163-10

Cardiovascular toxicity of tobacco products
09/01/2018 - 08/31/2024 (Subcontract PI)
American Heart Association NIH NHLBI
5U54HL120163-10

Rapidly Advancing Discovery to Arrest the Outbreak of Youth Vaping (VAPERACE)
07/01/2020 - 06/30/2024 (PI)
American Heart Association


Investigating pathways related to diabetes, obesity, and cardiovascular disease risk: SFRN CM Cooperative Project - supplement
04/01/2021 - 03/31/2024 (Subcontract PI)
The Brigham and Women's Hospital, Inc. American Heart Assoc


Restoring Vascular and Endothelial Health in Patients with Diabetes Mellitus
01/01/2020 - 12/31/2023 (Subcontract PI)
The Brigham and Women's Hospital, Inc. American Heart Assoc


Restoring Vascular and Endothelial Health in Patients with Diabetes Mellitus
01/01/2020 - 12/31/2023 (PI)
American Heart Association


Arterial Inflammation and Coronary Microvascular Dysfunction among Women with HIV: Missing Pieces to the MI Risk Puzzle
08/09/2019 - 07/31/2023 (Subcontract PI)
The General Hospital Corporation d/b/a Massachusetts General Hospital NIH NHLBI
5R01HL146267-04

The Association of Metabolic Disease and Pulmonary Hypertension
08/01/2022 - 06/30/2023 (Subcontract PI)
Beth Israel Deaconess Medical Center, Inc. NIH NHLBI
7R01HL134893-06

Showing 10 of 38 results. Show All Results

ACTIV-4C Post-Hospital Platform
03/23/2021 - 06/30/2024 (PI)
Versiti Wisconsin, Inc. National Heart, Lung
1OT2HL156812-01

ACTIV-4 Inpatient Platform
11/09/2020 - 06/30/2024 (PI)
Versiti Wisconsin, Inc. National Heart, Lung

Vascular Medicine Fellowship Program at Boston Medical Center Corporation
07/01/2022 - 09/30/2023 (PI)
Anticoagulation Forum

Vascular Medicine Fellowship Program
07/01/2021 - 06/30/2022 (PI)
Anticoagulation Forum

Vascular Medicine Fellowship Program
07/01/2020 - 06/30/2022 (PI)
Anticoagulation Forum

Servier Research Agreement-Amendment 5
11/01/2002 - 09/01/2016 (PI)
Servier


Title


Yr Title Project-Sub Proj Pubs
2024 Endothelial Cell Health Across the Spectrum of Cardiometabolic Disease 5R01HL168889-02
2024 Long-Term Endothelial Effects of COVID-19 in Obesity 5R01HL160003-03
2023 Endothelial Cell Health Across the Spectrum of Cardiometabolic Disease 1R01HL168889-01
2023 Long-Term Endothelial Effects of COVID-19 in Obesity 5R01HL160003-02
2022 Long-Term Endothelial Effects of COVID-19 in Obesity 1R01HL160003-01A1
2020 Multidisciplinary Training in Cardiovascular Research 5T32HL007224-45 195
2019 Multidisciplinary Training in Cardiovascular Research 5T32HL007224-44 195
2017 Mitochondrial Dynamics and UCP2 - Endothelial Dysfunction in Human Obesity 5R01HL115391-05 22
2016 Mitochondrial Dynamics and UCP2 - Endothelial Dysfunction in Human Obesity 4R01HL115391-04 22
2015 Mitochondrial Dynamics and UCP2 - Endothelial Dysfunction in Human Obesity 5R01HL115391-03 22
Showing 10 of 18 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Cooper LL, Prescott BR, Xanthakis V, Benjamin EJ, Vasan RS, Hamburg NM, Long MT, Mitchell GF. Association of Aortic Stiffness and Pressure Pulsatility With Noninvasive Estimates of Hepatic Steatosis and Fibrosis: The Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2024 Jul; 44(7):1704-1715.View Related Profiles. PMID: 38752348; PMCID: PMC11209780; DOI: 10.1161/ATVBAHA.123.320553;
     
  2. Kosyakovsky LB, Liu EE, Wang JK, Myers L, Parekh JK, Knauss H, Lewis GD, Malhotra R, Nayor M, Robbins JM, Gerszten RE, Hamburg NM, McNeill JN, Lau ES, Ho JE. Uncovering Unrecognized Heart Failure With Preserved Ejection Fraction Among Individuals With Obesity and Dyspnea. Circ Heart Fail. 2024 May; 17(5):e011366.View Related Profiles. PMID: 38742409; PMCID: PMC11214582; DOI: 10.1161/CIRCHEARTFAILURE.123.011366;
     
  3. Bonaca MP, Hamburg NM, Creager MA. Stepping Into the Future of Care for Patients With Peripheral Artery Disease. Circulation. 2024 Jun 11; 149(24):1862-1864. PMID: 38743808
     
  4. Boelitz KM, Forsyth A, Crawford A, Simons JP, Siracuse JJ, Farber A, Hamburg N, Eberhardt R, Schanzer A, Jones DW. Polyvascular disease is common in patients undergoing carotid endarterectomy and lower extremity bypass and is associated with worse outcomes. J Vasc Surg. 2024 May 08.View Related Profiles. PMID: 38723911
     
  5. Rawal S, Randhawa V, Rizvi SHM, Sachan M, Wara AK, Pérez-Cremades D, Weisbrod RM, Hamburg NM, Feinberg MW. miR-369-3p ameliorates diabetes-associated atherosclerosis by regulating macrophage succinate-GPR91 signaling. Cardiovasc Res. 2024 May 04.View Related Profiles. PMID: 38703377
     
  6. Hamburg NM, Moore KJ. Introduction to the Compendium On Environmental Impacts on Cardiovascular Health and Biology. Circ Res. 2024 Apr 26; 134(9):1047. PMID: 38662857
     
  7. Blaustein JR, Quisel MJ, Hamburg NM, Wittkopp S. Environmental Impacts on Cardiovascular Health and Biology: An Overview. Circ Res. 2024 Apr 26; 134(9):1048-1060. PMID: 38662864; PMCID: PMC11058466; DOI: 10.1161/CIRCRESAHA.123.323613;
     
  8. Yang JY, Mondéjar-Parreño G, Jahng JWS, Lu Y, Hamburg N, Nadeau KC, Conklin DJ, Liao R, Chandy M, Wu JC. Elucidating effects of the environmental pollutant benzo[a]pyrene [BaP] on cardiac arrhythmogenicity. J Mol Cell Cardiol. 2024 Jun; 191:23-26. PMID: 38648962
     
  9. Minetti ET, Erythropel HC, Keith R, Davis DR, Zimmerman JB, Krishnan-Sarin S, Hamburg NM. Cardiovascular Health Effects and Synthetic Cooling Agents in E-cigarettes Labeled as 'clear' Marketed in Massachusetts After the Tobacco Product Flavoring Ban. medRxiv. 2024 Apr 19. PMID: 38699355; PMCID: PMC11065038; DOI: 10.1101/2024.04.18.24305863;
     
  10. Siracuse JJ, Menard MT, Rosenfield K, Conte MS, Powell R, Hamburg N, Doros G, Strong MB, Farber A. Characterization of cardiovascular serious adverse events after bypass or endovascular revascularization for limb-threatening ischemia in the BEST-CLI trial. J Vasc Surg. 2024 Apr 16.View Related Profiles. PMID: 38626847
     
Showing 10 of 225 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 225 publications over 21 distinct years, with a maximum of 26 publications in 2016

YearPublications
20001
20042
20051
20074
20084
20094
20107
20119
20129
201310
201413
201512
201626
201722
201811
20198
202011
202123
202215
202317
202416

2010-2010 Department of Medicine: Dawson Junior Faculty Development Award
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Endothelium
Epidemiology
Insulin Resistance
Peripheral vascular diseases
Risk factors

Available to Mentor as: (Review Mentor Role Definitions):
  • Career Mentor
  • Diversity Mentor
  • Education Mentor
  • Project Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:

75 E. Newton St Collamore Building
Boston MA 02118
Google Map


Hamburg's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department